Wang Lingling, Sun Ruiqi, Tian Lidan, Xu Richard Huan
Center for Health Policy and Management Studies, Nanjing University, Nanjing, China.
Department of Blood Transfusion Medicine, Jinling Hospital, School of Medicine, Nanjing University, Nanjing, China.
Asia Pac J Oncol Nurs. 2024 Jul 5;11(9):100552. doi: 10.1016/j.apjon.2024.100552. eCollection 2024 Sep.
The aim of this study was to assess the level of financial toxicity (FT) experienced by the following three age groups of cancer patients in China: young working-aged patients (age < 40 years), middle-aged patients (40-64 years), and older patients (≥ 65 years).
The data used for this study were collected via a cross-sectional survey conducted in China. FT was assessed using the Comprehensive Score for Financial Toxicity (COST). ANOVA was used to examine the differences in FT status between age groups. Multivariate linear regression models were employed to assess the association between age and FT, adjusted by socioeconomic and other clinical characteristics.
A total of 556 cancer patients completed the survey. Approximately 54.3% of the participants were male and 45.7% were female. The majority (61.5%) were aged 40-64 years, while 27.7% were aged 65 or older. The mean FT scores for young patients (< 40 years), middle-aged patients (40-64 years), and older patients (≥ 65 years) were 16.7, 12.8, and 12.4, respectively. The results of the regression analysis revealed that, without adjusting for background characteristics, young patients had significantly higher mean COST scores. This suggests they experienced lower levels of FT compared to patients in other age groups. Stratified analysis revealed that, for older patients, only educational level and type of insurance scheme were significant factors in predicting the COST score.
This study provides empirical evidence for developing targeted interventions and policies to reduce the FT for patients in different age groups. Given that FT is complicated, a longitudinal study should be conducted to explore the long-term impact of FT on cancer patients' quality of life and well-being.
本研究旨在评估中国以下三个年龄组癌症患者所经历的财务毒性(FT)水平:年轻在职患者(年龄<40岁)、中年患者(40 - 64岁)和老年患者(≥65岁)。
本研究使用的数据通过在中国进行的横断面调查收集。使用财务毒性综合评分(COST)评估财务毒性。采用方差分析检验年龄组之间财务毒性状况的差异。采用多元线性回归模型评估年龄与财务毒性之间的关联,并根据社会经济和其他临床特征进行调整。
共有556名癌症患者完成了调查。约54.3%的参与者为男性,45.7%为女性。大多数(61.5%)年龄在40 - 64岁之间,而27.7%的年龄在65岁及以上。年轻患者(<40岁)、中年患者(40 - 64岁)和老年患者(≥65岁)的平均财务毒性得分分别为16.7、12.8和12.4。回归分析结果显示,在不调整背景特征的情况下,年轻患者的平均COST得分显著更高。这表明与其他年龄组的患者相比,他们经历的财务毒性水平较低。分层分析显示,对于老年患者,只有教育水平和保险计划类型是预测COST得分的重要因素。
本研究为制定有针对性的干预措施和政策以降低不同年龄组患者的财务毒性提供了实证依据。鉴于财务毒性情况复杂,应开展纵向研究以探讨财务毒性对癌症患者生活质量和幸福感的长期影响。